Target intelligence / Profile preview

Fanconi anemia core complex-associated protein 24 (FAAP24)

Target
FAAP24
Molecular classification
Other (DNA repair protein, member of Fanconi anemia pathway, XPF/MUS81 family-like pseudo-nuclease domain)
01

Overview

Fanconi anemia core complex-associated protein 24 (FAAP24) is a DNA repair protein that forms a heterodimer with FANCM and anchors the Fanconi anemia (FA) core complex to chromatin at sites of DNA damage, primarily repairing DNA interstrand crosslinks[1][2][3][6]. FAAP24 contains a pseudo-nuclease domain and a helix-hairpin-helix (HhH)2 domain, and is structurally related to XPF/MUS81 endonucleases but lacks nuclease activity[1][2]. The FAAP24–FANCM complex recognizes and binds to single-stranded and branched DNA structures and is essential for the recruitment and activation of the FA pathway, which includes the monoubiquitination of FANCD2 and checkpoint signaling via ATR in response to replication stress and DNA crosslinks[2][3][4][6]. Loss of FAAP24 function results in genomic instability and hypersensitivity to DNA crosslinking agents, and is mechanistically implicated in the pathogenesis of Fanconi anemia, a rare inherited disorder predisposing to cancer due to faulty DNA repair[2][3][5]. FAAP24 is not a traditional direct therapeutic target (such as a receptor or enzyme), but its central role in DNA repair and genomic stability makes it a significant focus in studies of cancer susceptibility and synthetic lethality approaches[2][3][5][6].

Other names
Fanconi anemia-associated protein of 24 kDaC19orf40FLJ46828MGC32020
02

Biological functions

DNA repair (repair of DNA interstrand crosslinks)Recruitment of the Fanconi anemia core complex to damaged DNAMonoubiquitination of FANCD2 (critical DNA repair signaling event)ATR-mediated S-phase checkpoint activationMaintenance of genomic integrity
03

Disease associations

Cancer (due to DNA repair defects, notably associated with Fanconi anemia)Other (genomic instability syndromes)

Beyond the preview

Go deeper on Fanconi anemia core complex-associated protein 24 (FAAP24).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fanconi anemia core complex-associated protein 24 (FAAP24).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call